Viewing Study NCT03202667


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-04-11 @ 5:25 PM
Study NCT ID: NCT03202667
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2017-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
Sponsor: University Hospital, Basel, Switzerland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module